ESR3 – Krishna Vippala (TEVA)

Background: Biotechnology

Profile: Krishna has a Master’s degree in Biotechnology and Bioinformatics from La Trobe University, Melbourne, where he has studied how mutations in Profilin-1 causes aggregates in cytoskeleton with the help of gfp-tag and fluorescent microscopy. He then moved to pharma industry in India where he worked on developing processes for purifying and characterizing biosimilars. Krishna is currently doing his PhD on developing oral nano-delivery formulation under the supervision of Prof Amir from TAU and Dr. Avramovitch from Teva.

ETN Topic: Oral nano delivery – Formulation design and characterization